Ind-Swift Laboratories Limited Share Price Bombay S.E.
Stocks
INDSWFTLAB
INE915B01019
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 176.05 INR | +4.48% |
|
+7.83% | +99.17% |
| Market Cap | 1.14TCr 12Cr 11Cr 9.71Cr 9.14Cr 17Cr 17Cr 115.55Cr 45Cr 561.63Cr 45Cr 44Cr 1.95TCr | P/E 2024 |
1.41x | P/E 2025 | 2.38x |
|---|---|---|---|---|---|
| Enterprise Value | 713.1Cr 7.57Cr 6.59Cr 6.08Cr 5.72Cr 11Cr 11Cr 72Cr 28Cr 351.43Cr 28Cr 28Cr 1.22TCr | EV / Sales 2024 |
0.14x | EV / Sales 2025 | 0.12x |
| Free-Float |
40.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.24% | ||
| 1 week | +7.83% | ||
| Current month | +15.60% | ||
| 1 month | +30.64% | ||
| 3 months | +23.57% | ||
| 6 months | +87.90% | ||
| Current year | +99.17% |
| 1 week | 158.3 |  | 178.65 |
| 1 month | 129.5 | | 178.65 |
| Current year | 88.5 | | 178.65 |
| 1 year | 87 | | 178.65 |
| 3 years | 67.15 | | 186 |
| 5 years | 51.1 | | 186 |
| 10 years | 15.25 | | 186 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 04/01/1995 | |
Himanshu Jain
CEO | Chief Executive Officer | 43 | 15/06/2011 |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 29/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Himanshu Jain
BRD | Director/Board Member | 43 | - |
| Chairman | 74 | - | |
Rishav Mehta
BRD | Director/Board Member | 35 | 23/03/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.48% | +7.83% | - | - | 15Cr | |
| +0.56% | +1.31% | +11.16% | +82.81% | 4.63TCr | |
| -3.23% | +2.84% | +49.62% | +90.59% | 3.47TCr | |
| +0.39% | -2.19% | -8.42% | +34.39% | 1.16TCr | |
| +0.23% | -2.72% | +13.11% | +93.92% | 1.13TCr | |
| -0.57% | +2.14% | +38.16% | +129.26% | 927.2Cr | |
| -1.02% | +0.26% | +12.20% | +39.05% | 713.07Cr | |
| -1.73% | +1.13% | +43.06% | -18.68% | 659.71Cr | |
| +0.37% | -0.75% | +31.63% | +236.91% | 638.89Cr | |
| +0.73% | -2.44% | -37.77% | -7.15% | 497.53Cr | |
| Average | -0.07% | -0.19% | +16.97% | +75.68% | 1.54TCr | |
| Weighted average by Cap. | -0.78% | +0.94% | +21.91% | +81.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.3TCr 14Cr 12Cr 11Cr 10Cr 19Cr 20Cr 131.53Cr 51Cr 639.31Cr 52Cr 51Cr 2.22TCr | 561.71Cr 5.96Cr 5.19Cr 4.79Cr 4.5Cr 8.42Cr 8.48Cr 57Cr 22Cr 276.82Cr 22Cr 22Cr 959.46Cr |
| Net income | 420.96Cr 4.47Cr 3.89Cr 3.59Cr 3.37Cr 6.31Cr 6.36Cr 43Cr 17Cr 207.45Cr 17Cr 16Cr 719.04Cr | 250.48Cr 2.66Cr 2.32Cr 2.13Cr 2.01Cr 3.76Cr 3.78Cr 25Cr 9.86Cr 123.44Cr 9.98Cr 9.76Cr 427.84Cr |
| Net Debt | -415.31Cr -4.41Cr -3.84Cr -3.54Cr -3.33Cr -6.23Cr -6.27Cr -42Cr -16Cr -204.67Cr -17Cr -16Cr -709.38Cr | -426.55Cr -4.53Cr -3.94Cr -3.64Cr -3.42Cr -6.4Cr -6.44Cr -43Cr -17Cr -210.21Cr -17Cr -17Cr -728.59Cr |
Employees
1,246
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 176.05 ₹ | +4.48% | 34,578 |
| 18/26/18 | 168.50 ₹ | +3.69% | 1,14,686 |
| 17/26/17 | 162.50 ₹ | -0.21% | 33,940 |
| 16/26/16 | 162.85 ₹ | +0.68% | 37,697 |
| 15/26/15 | 161.75 ₹ | -0.71% | 47,632 |
- Stock Market
- Stocks
- INDSWFTLAB Stock
- INDSWFTLAB Stock
Select your edition
All financial news and data tailored to specific country editions
